What is APLS's dilution risk score?

APLS has a latest available DilutionScore record of 25/100, categorized as low dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for APLS, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for APLS?

DilutionWatch tracks 25 SEC filing types for APLS including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect APLS shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For APLS, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for APLS tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for APLS. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

APLS Dilution Risk Score: 25/100 (LOW)

Score Breakdown

📋 Offering Ability

20

💰 Cash Runway

40

📊 Float Risk

25

⚠️ Warrant Exposure

15

🔄 Convertible Debt

15

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for APLS.

🔔 Track APLS — Get forecast alerts →

Market Data

Market Cap$5.25B

Shares Outstanding128.02M

Float83.22M

Cash$529.57M

Debt$94.78M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 36.8% shares (2026Q1 vs prior)

330 institutional holders · 183.63M shares

#1 MORGAN STANLEY 28.86M shares

#2 Avoro Capital Advisors LLC 24.44M shares

#3 BlackRock, Inc. 13.54M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

No current FINRA short-interest record is available for this ticker.

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2022-12-31

4 INSIDER TRANSACTION 2026-05-01

4 INSIDER TRANSACTION 2026-04-20

4 INSIDER TRANSACTION 2026-04-08

3 FORM3 2026-04-06

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual APLS Dilution Snapshot

Apellis Pharmaceuticals, Inc. (APLS) has a DilutionScore of 25/100, rated Low dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for APLS: 4 on 2026-05-01; 4 on 2026-04-20; 4 on 2026-04-08.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.